Page last updated: 2024-09-05

sb 203580 and kr 31378

sb 203580 has been researched along with kr 31378 in 1 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (kr 31378)	Trials (kr 31378)	Recent Studies (post-2010) (kr 31378)
3,489	4	1,137	20	0	0

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jung, YS; Kim, E; Lee, DH; Lim, H; Yi, KY; Yoo, SE	1

Other Studies

1 other study(ies) available for sb 203580 and kr 31378

Article	Year
KR-31378 protects cardiac H9c2 cells from chemical hypoxia-induced cell death via inhibition of JNK/p38 MAPK activation. The Japanese journal of physiology, 2004, Volume: 54, Issue:6 Topics: Animals; Anthracenes; Butadienes; Cell Death; Cell Hypoxia; Cell Line; Enzyme Activation; Guanidines; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Molecular Structure; Myocardium; Nitriles; p38 Mitogen-Activated Protein Kinases; Pyrans; Pyridines; Reactive Oxygen Species	2004

Article

Year

KR-31378 protects cardiac H9c2 cells from chemical hypoxia-induced cell death via inhibition of JNK/p38 MAPK activation.

The Japanese journal of physiology, 2004, Volume: 54, Issue:6

Topics: Animals; Anthracenes; Butadienes; Cell Death; Cell Hypoxia; Cell Line; Enzyme Activation; Guanidines; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Molecular Structure; Myocardium; Nitriles; p38 Mitogen-Activated Protein Kinases; Pyrans; Pyridines; Reactive Oxygen Species

2004